Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum

Infection and Immunity

Volumn 65, Issue 3, 1997, Pages 936-942

  Zhou, Ping ^a   Sieve, Myra C ^a   Tewari, Ram P ^b   Seder, Robert A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CELL INTERACTION; COMBINED IMMUNODEFICIENCY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT PLANNING;

EID: 0031019290     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.3.936-942.1997     Document Type: Article

References (40)

1. Barral-Netto, M., A. Barral, C. E. Brownell, Y. A. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257:545-548.
2. Bistoni, F., A. Vecchiarelli, R. Mazzolla, P. Puccetti, P. Marconi, and E. Garaci. 1985. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans. Antimicroh. Agents Chemother. 27:625-631.
3. Brummer, E., N. Kurita, S. Yoshida, K. Nishimura, and M. Miyaji. 1991. Killing of Histoplasma capsulatum by -γ-interferon-activatcd human monocyte-derived macrophages: evidence for a Superoxide anion-dependcnt mechanism. J. Med. Microbiol. 35:29-34.
4. Cherwinski, H., J. Schumacher, K. Brown, and T. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
5. Chia, J. K. S., and E. J. McManus. 1990. In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations. Antimicrob. Agents Chemother. 34:906-908.
6. Chia, J. K. S., and M. Pollack. 1989. Amphotericin B induces tumor necrosis factor production by murine macrophages. J. Infect. Dis. 159:113-116.
7. Clemons, K. V., E. Brummer, and D. A. Stevens. 1994. Cytokine treatment of central nervous system infection: efficacy of intcrleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:460-464.
8. Curry, R. C., P. A. Keiner, and F. W. Fitch. 1987. A sensitive immunochemical assay for biologically active Mu IFN-γ. J. Immunol. Methods 104:137-142.
9. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Pagani, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuciear cells: priming for IL-12 and TNF-a production. J. Exp. Med. 181:537-546.
10. + T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol. 152:3491-3500.
11. Deepe, G. S., Jr. 1994. The immune response to Histoplasma capsulatum: unearthing its secrets. J. Lab. Clin. Med. 123:201-205.
12. Fleischmann, J., B. Wu-Hsieh, and D. H. Howard. 1990. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-γ. J. Infect. Dis. 161:143-145.
13. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin-12 is required for the T lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115-6119.
14. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
15. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington. 1995. Transforming growth factor-β inhibits interleukin-12-induced production of interferon-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:994-1000.
16. Jeannin, P., Y. Deineste, M. Seveso, P. Life, and J.-Y. Bonnefoy. 1996. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J. Immunol. 156:3159-3165.
17. Johnson, P. C., N. Khardori, A. F. Najjar, F. Butt, P. W. A. Mansell, and G. A. Sarosi. 1988. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:152-158.
18. Lin, H.-S., D. Medoff, and G. S. Kobayashi. 1977. Effects of amphotericin B on macrophages and their precursor cells. Antimicrob. Agents Chemother. 11:154-160.
19. Medoff, G., F. Yaleriote, R. G. Lynch, D. Schlessinger, and G. Kobayashi. 1974. Synergistic effect of amphotericin B and 1.3-bis(2-chloroelhyl)-1-nitro- sourea against a iransplantable AKR leukemia. Cancer Res. 34:974-978.
20. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047-1056.
21. Newman, S. L., and L. Gootee. 1492. Colony-stinuiialing factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect, Immun. 60:4593-4597.
22. Nightingale, S. D., J. M. Parks, S. M. Pounders, D. K. Burns, J. Reynolds, and J. A. Hernandez. 1990. Disseminated histoplasmosis in patients with AIDS. South. Med. J. 83:624-630.
23. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T- lymphocyte function. Curr. Opin. Immunol. 6:458-466.
24. - large granular lymphocyte functions. J. Immunol. 146:3791-3798.
25. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241-251.
26. + T cells. Eur. J. Immunol. 24:343-347.
27. - T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24:793-798.
28. + T cells to enhance priming for interfcron γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188-10192.
29. Shirley, S. F., and J. R. Little. 1979. Immunopotentiating effects of amphotericin B. I. Enhanced contact sensitivity in mice. J. Immunol. 123:2878-2882.
30. Starns, H. F., M. K. Pearce, A. Tewari, J. H. Yim, J.-C. Zou, and J. S. Abrams. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor challenge in mice. J. Immunol. 145:4185-4191.
31. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
32. Thomas, M. Z., G. Medoff, and G. S. Kobayashi. 1973. Changes in murine resistance to Listeria monocytogenes infection induced by amphotericin B. J. Infect. Dis. 127:373-377.
33. Tripp, C. J., R. D. Schreiber, and E. R. Unanue. 1993. Interleukin-12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin-10 is a physiological antagonist. Proc. Natl. Acad. Sci. USA 90:3725-3729.
34. Wheat, J., R. Hafner, M. Wulfsohn, P. Spencer, K. Squires, W. Powderly, B. Wong, M. Rinaldi, M. Saag, R. Hamill, R. Murphy, P. Connolly-Stringfield, N. Briggs, and S. Owens. 1993. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 118:610-616.
35. Wheat, L. J., P. A. Connolly-Stringfield, R. L. Baker, M. F. Curfman, M. E. Eads, K. S. Israel, S. A. Norris, D. H. Webb, and M. L. Zeckel. 1990. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 69:361-374.
36. Wolf, J. E., and S. E. Massof. 1990. In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B. Infect. Immun. 58: 1296-1300.
37. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Immunol. 146:3074-3081.
38. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594-596.
39. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25: 672-676.
40. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 155:785-795.